發(fā)布時間：2018-05-06 19:42

  本文選題：抗高血壓藥 + 限定日劑量��； 參考：《中國藥房》2015年20期

【摘要】：目的:為臨床合理用藥和科學管理提供參考。方法:采用世界衛(wèi)生組織推薦的限定日劑量為指標的分析方法,對武漢地區(qū)34家醫(yī)院2011-2013抗高血壓藥有關數(shù)據(jù)進行統(tǒng)計、分析。結(jié)果:武漢地區(qū)2011-2013年抗高血壓藥銷售金額和用藥頻度逐年增加,鈣通道阻滯藥(CCB)的銷售金額和用藥頻度最高,構(gòu)成比均達到40%左右,其次是血管緊張素Ⅱ受體拮抗藥(ARB)和血管緊張素轉(zhuǎn)換酶抑制劑(ACEI),新型復方制劑的銷售金額和用藥頻度也明顯增加。單藥品種銷售金額排名前3位的分別是氨氯地平、左旋氨氯地平和纈沙坦,用藥頻度居于前3位的是氨氯地平、硝苯地平和非洛地平。結(jié)論:武漢地區(qū)CCB、ARB、ACEI、腎上腺素受體阻滯藥和利尿藥最常用,符合目前抗高血壓用藥原則,臨床應用基本合理。
[Abstract]:Objective: to provide reference for clinical rational drug use and scientific management. Methods: the data of antihypertensive drugs in 34 hospitals in Wuhan area from 2011 to 2013 were analyzed and analyzed by using the limited daily dose recommended by the World Health Organization as the index. Results: the sales amount and frequency of antihypertensive drugs in Wuhan area increased year by year, and CCB (calcium channel blocker) was the most frequently used, and the composition ratio of CCB was about 40%. The second was angiotensin 鈪，

本文編號：1853620